BiotechTube
Home/Pipeline/eOPN3‑Trigeminal Neuropathic Pain

eOPN3‑Trigeminal Neuropathic Pain

Trigeminal Neuropathic Pain

PreclinicalActive

Key Facts

Indication
Trigeminal Neuropathic Pain
Phase
Preclinical
Status
Active
Company
Modulight Bio

About Modulight Bio

Israeli optogenetics biotech leveraging light‑controlled GPCRs to treat refractory neurological disorders.

View full company profile

Therapeutic Areas

NeurologyPainEpilepsyMovement Disorders